Metabolism/Cardiovascular Disease Evaluation Platform
SMOC Metabolic/Cardiovascular Disease Evaluation Platform, spearheaded by a multidisciplinary team of disease model specialists, integrates validated metabolic/cardiovascular models (e.g., diet-induced obesity, ApoE−KO atherosclerosis) with proprietary model development pipelines.
The platform offers comprehensive drug evaluation services, including drug metabolism, imaging, behavioral studies, histopathology, and molecular biomarker detection.
